NCT06250920

Brief Summary

To assess the efficacy and safety of virtual reality-based visual training (VRVT) in myopia control among children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

February 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

9 months

First QC Date

February 1, 2024

Last Update Submit

February 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • changes in axial length

    baseline and the 3-month follow-up visits

Secondary Outcomes (1)

  • changes in subfoveal choroidal thickness

    baseline and the 3-month follow-up visits.

Study Arms (2)

Virtual reality-based visual training group

EXPERIMENTAL
Device: Virtual reality visual training

Single-Vision Spectacle Group

NO INTERVENTION

Interventions

Children in intervention group were administered at home under the supervision of parents for 20 minutes per session every day with virtual reality visual training

Virtual reality-based visual training group

Eligibility Criteria

Age8 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 8-13 years old (inclusive), regardless of gender;
  • The spherical equivalent of both eyes after cycloplegia was -3.00D to -0.50D (including);
  • Binocular astigmatism ≤3.00D during screening;
  • Anisometropia (according to spherical equivalent) ≤1.50D during screening;
  • The intraocular pressure of any eye during screening was ≤21mmHg;
  • At the time of screening, the best corrected distance visual acuity of any eye was ≥1.0 or LogMAR≤0;
  • Good binocular stereopsis and stereopsis acuity ≤60 ";
  • The subjects and their legal guardians were willing to participate in the study and signed written informed consent.

You may not qualify if:

  • Existing or previous history of ophthalmic organic diseases, ophthalmic surgery, and obvious strabismus after wearing glasses;
  • Using orthokeratology lenses, feeding instrument and other myopia prevention and control methods that may affect the study in the past 6 months;
  • Subjects with poor vestibular function such as motion sickness and seasickness;
  • Any history of diseases or syndromes that may cause severe myopia (e.g., Marfan syndrome, Stickler syndrome, retinopathy of prematurity, etc.); 5, any eye refractive media abnormalities (such as cornea, lens abnormalities, etc.);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, 270002, China

Location

Related Publications (1)

  • Xu Z, Zou A, Li L, Wu Y, Cai W, Ma J, Yu J. Effect of virtual reality-based visual training for myopia control in children: a randomized controlled trial. BMC Ophthalmol. 2024 Sep 16;24(1):358. doi: 10.1186/s12886-024-03580-w.

MeSH Terms

Conditions

MyopiaMyopia, Degenerative

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

February 1, 2024

First Posted

February 9, 2024

Study Start

December 1, 2020

Primary Completion

August 30, 2021

Study Completion

August 30, 2021

Last Updated

February 9, 2024

Record last verified: 2024-02

Locations